AzTrials
AzTrials

Any Condition Requiring Surgical Treatment Via ColectomyNCT02044770

ENSEAL® G2 Articulating Tissue Sealer in Laparoscopic Colectomy

An observational study of Any Condition Requiring Surgical Treatment Via Colectomy, run by Ethicon Endo-Surgery at 3 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary objective of this clinical study is to describe the initial clinical experience with ENSEAL® G2 Articulating Tissue Sealer in laparoscopic colectomy, quantifying and/or qualifying how its articulation feature enables optimization of vessel sealing through improved access, approach, and visibility. Read more about this study

Who is it for?
Ages 18 to 80 years
How many people
29 participants
Where
3 sitesUnited States
Study dates
Jan 2014to Jun 2014
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult participants (age ≥ 18 and < 80 years of age, on the day of the procedure), scheduled to undergo a planned colectomy, anticipated to be performed laparoscopically

Who may be able to join

  • Adult participants (age ≥ 18 and < 80 years of age, on the day of the procedure
  • Scheduled to undergo one of the following planned colectomies, anticipated to be performed laparoscopically:
  • Right colectomy; b. Left hemicolectomy; c. Transverse colectomy; d. Sigmoidectomy; e. Total colectomy; or f. Subtotal colectomy. f. Subtotal colectomy.

Who cannot join

  • Unable or unwilling to sign the study informed consent form;
  • Previous colectomy and/or proctectomy;
  • Anticipated combinations of laparoscopic colectomy and low anterior resection, except in cases in which the lower anterior resection is intended to be done with an energy device other than the ENSEAL® G2 Articulating Tissue Sealer;
  • Any previous major surgery of the colon that, in the opinion of the surgeon, may increase the risk of intraoperative conversion to open surgery;
  • Surgery planned to be performed using a single port;
  • Surgery planned to be performed with a hand-assisted device;
  • Requiring emergency surgery;
  • Likely to require an energy tissue sealer/dissector with a shaft larger than 35cm during surgery;

Trial locations and contacts

3 sites in 1 country.

United States3 sites
  • The Christ Hospital

    Cincinnati, Ohio, 45219

  • Franciscan St. Francis Health

    Indianapolis, Indiana, 46237

  • Jersey Shore University medical Center

    Neptune City, New Jersey, 07753

Other trials in United States

About this study

Official title: Initial Clinical Experience With the ENSEAL® G2 Articulating Tissue Sealer in Laparoscopic Colectomy

The primary objective of this clinical study is to describe the initial clinical experience with ENSEAL® G2 Articulating Tissue Sealer in laparoscopic colectomy, quantifying and/or qualifying how its articulation feature enables optimization of vessel sealing through improved access, approach, and visibility. This is an observational study of device usage being conducted to report initial experience with the ENSEAL ART device. It is not intended as hypothesis testing.

Read the detailed description

The ENSEAL® G2 Tissue Sealer is a sterile, single-patient use surgical instrument used to coagulate and transect vessels up to and including 7mm in diameter and tissue and/or vascular bundles. In preclinical research using ENSEAL tissue sealers, burst pressures were 51% higher for perpendicularly sealed vessels than for angled seals (p<0.001) and the seal length was the primary variable in determining burst pressure (Voegele AC, 2013). These results suggest that the strongest possible seal may be obtained when vessels are approached perpendicularly and not at an angle.

However, desired angles for vessel sealing cannot always be obtained in the surgical field, especially in laparoscopic surgery due mostly to the fixed nature of the abdominal wall cannulas and the lack of adequate articulating hemostatic tools.

Since strong vessel seals are important for adequate homeostasis, the value of an articulating vessel-sealing device primarily resides in its ability to maneuver around corners and behind structures in confined spaces. An articulating vessel-sealing device would maximize the ability to approach vessels or bundles in a perpendicular manner to provide greater seal strength.

ENSEAL ART is the first articulating advanced bipolar device that can facilitate laparoscopic surgery through a 5mm port. The instrument shaft, can achieve up to 110 degrees of articulation (which improves the visibility of the tip of the device's jaw) to gain access to tissue in challenging anatomy, especially in deep/tight spaces, and facilitate additional angles to transect and seal tissue, vessels, and vascular bundles.

The articulation feature and improved ergonomics of the ENSEAL ART may provide the ability to maneuver around corners and behind structures, while making it easier to capture the full vessel in a single bite. These features may lead to a reduction of the number of ports, the instrument exchanges between ports, the need to pass the energy device to an assistant, and the number of times the surgical table tilt has to be changed during certain laparoscopic surgical procedures (e.g., colectomy).

This study focuses primarily in reporting initial user-centered interactions with the ENSEAL ART device. The users of the device will be board-certified colorectal surgeons, who will use it in an actual clinical setting (i.e., laparoscopic colectomies).

After obtaining Institutional Review Board approval, the study sites will begin recruitment of study participants.

At each of the participating study sites, 8 to 14 participants will undergo a laparoscopic colectomy using the ENSEAL ART for vessel dissection and sealing, according to the institution's standard approach.

Video recordings from the laparoscope and external cameras will capture all device activations completed with the ENSEAL ART device using articulation vs. straight (without articulating). After each surgical case, PIs will complete a survey related to the perceived advantages of the articulating features of ENSEAL ART in the context of their experience using non-articulation tissue sealers. PIs will also complete an assessment (using a validated tool) of the perceived workload of the use of the ENSEAL ART device.

The digital video recording of the surgical procedure will be evaluated by a consultancy group - Design Science Consulting Inc. (Philadelphia, PA), specializing in the conduct of field research of the variables pre-established by the protocol. Design Science is a third party reviewer, not associated with any of the study sites.

Subject-related data to be collected is limited to age, gender, diagnosis, Medical History, and adverse events associated to the use of the device.

Keywords
laparoscopic, colectomy, ENSEAL

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of articulated activations

    Number of device activations while the device is articulated

    Measured: Intraoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jan 2014 (estimated)
  2. Study startJan 2014
  3. Primary completionJun 2014
  4. Study completionJun 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Time perspective
Prospective
Enrolment
29 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02044770
Sponsor's protocol ID
ENG 13-001
Status last verified
Sep 2014
First submitted
22 Jan 2014
Last updated
29 Apr 2015
Results posted
No
Data monitoring committee
No

Publications

  • Glenn S. Parker MD, Ben M. Tsai MD, Dipen C. Maun MD, Janice F. Rafferty MD, Michael J. Stamos MD, Edward G. Chekan MD, Michael Schwiers, and Mario Gutierrez (2015)

Questions about this trial

What is this clinical trial studying?

An observational study of Any Condition Requiring Surgical Treatment Via Colectomy, run by Ethicon Endo-Surgery at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Apr 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of articulated activations (time frame: Intraoperative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02044770, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in